email: contact@intelliseq.com

Cooperation with Adamed during MIT Enterprise Forum CEE acceleration program

In 2019, we got to the finals of the MITEF Central Eastern Europe acceleration program. MITEF CEE is a part of the global network of MIT Enterprise Forum, affiliated with the world’s best technology university – the Massachusetts Institute of Technology. The aim of the program is to support the development of the most innovative startups from Central and Eastern Europe by combining their potential with the knowledge and resources of leading enterprises as well as with the experience of Polish and international mentors.

During the acceleration program, we had an opportunity to cooperate with Adamed, a pharmaceutical and biotechnology company that manufactures and distributes worldwide medical goods that are used to treat chronic modern-age diseases in a number of therapeutic areas. The aim of our pilot study was to create a pharmacogenetic test prototype based on whole genome sequencing, which includes:

  • genotypes of genes involved in metabolism of two antidepressants drugs,
  • phenotype classification based on the scale: poor (PM), intermediate (IM), normal (NM) and ultrarapid metabolizer (UM),
  • CPIC-based recommendation for dosing based on the phenotype.

Read about and watch our cooperation with Adamed in the Rzeczpospolita: https://www.rp.pl/Farmacja/308269958-RZECZoBIZNESIE-Przyszlosc-farmacji-juz-jest-testowana.html